Loading…
GIND and BCEM share 9.9% of their holdings.
| Side by side | GIND | BCEM |
|---|---|---|
| Strategy | Commodities · Gold | International · Emerging |
| Expense ratio | 0.75% | 0.80% |
| Cost per year on $10k | $75 | $80 |
| Trailing 12-mo yield | 0.74% | 0.00% |
| Income per year on $10k | $74 | $0 |
| YTD | −10.3% | — |
| 1 year | −12.7% | — |
| 3 years · per year | — | — |
| 5 years · per year | — | — |
| Worst drop · 1Y | −21.0% | — |
| Volatility · 1Y | 17.5% | — |
| Holdings | 127 | 0 |
| Assets | $156M | $49M |
| Leverage | None | None |
| Since | 2025 | 2026 |
Highlighted = best in the row. Returns include dividends.